STRATA Skin Sciences, Inc. SSKN
Set alert
0.00 USD 0.00 0.00%
At close · Oct 29
0.16 +0.16 +79,350.00%
After hours · Oct 29, 4:00 PM ET
0.121 Day range 0.134
0.0001 52-week range 1.83
- YTD
- -99.98%
- 1 year
- -99.99%
- Open
- 0.134
- Prev close
- 0.0002
- Mkt cap
- 1.18K
- Vol
- 4.88K
- Avg vol
- 3.72K
- EPS
- -1.35
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.121
- High
- 0.134
- Forward P/E
- -2.53
- Beta
- 1.32
- Short ratio
- 0.44
- Inst. own
- 60.39%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.04
- 200-d avg
- 3.51
- 1y target
- 16.00
2Y chart
Events in this range
- Nov 13, 2024Earnings: -0.53; estimate 0; surprise —%
Signals (94)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 26, 2026 | 6 days ago |
| SMA: Bearish | Oct 9, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 9, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| RSI: Oversold | Sep 4, 2026 | 1 month ago |
| MACD: Buy Signal | Jul 28, 2026 | 3 months ago |
| RSI: Oversold | Jul 10, 2026 | 3 months ago |
| MACD: Sell Signal | Jun 30, 2026 | 4 months ago |
| SMA: Bearish | Jun 24, 2026 | 4 months ago |
| SMA: Bullish | Jun 23, 2026 | 4 months ago |
| SMA: Bearish | Jun 17, 2026 | 4 months ago |
| SMA: Bullish | Jun 16, 2026 | 4 months ago |
| RSI: Oversold | Apr 10, 2026 | 6 months ago |
| RSI: Oversold | Mar 11, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 4, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 12, 2026 | 8 months ago |
| RSI: Oversold | Feb 12, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 11, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 3, 2026 | 9 months ago |
| MACD: Buy Signal | Feb 2, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 29, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 28, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 27, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 29, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 18, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 28, 2025 | 11 months ago |
| SMA: Bearish | Oct 29, 2025 | 1 year ago |
| SMA: Bullish | Oct 28, 2025 | 1 year ago |
| SMA: Bearish | Oct 21, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 21, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 16, 2025 | 1 year ago |
| SMA: Bullish | Oct 14, 2025 | 1 year ago |
| SMA: Bearish | Oct 8, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 8, 2025 | 1 year ago |
| SMA: Bearish | Sep 24, 2025 | 1 year ago |
| SMA: Bullish | Sep 23, 2025 | 1 year ago |
| SMA: Bullish | Sep 23, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 23, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 8, 2025 | 1 year ago |
| SMA: Bearish | Sep 3, 2025 | 1 year ago |
| SMA: Bearish | Sep 3, 2025 | 1 year ago |
| SMA: Bullish | Sep 2, 2025 | 1 year ago |
| RSI: Overbought | Sep 2, 2025 | 1 year ago |
| SMA: Bullish | Aug 29, 2025 | 1 year ago |
| SMA: Bearish | Aug 28, 2025 | 1 year ago |
| SMA: Bullish | Aug 27, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 27, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 26, 2025 | 1 year ago |
| RSI: Oversold | Aug 26, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 13, 2025 | 1 year ago |
| RSI: Oversold | Aug 8, 2025 | 1 year ago |
| RSI: Oversold | Jul 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 17, 2025 | 1 year ago |
| SMA: Bearish | Jul 3, 2025 | 1 year ago |
| SMA: Bullish | Jul 2, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 23, 2025 | 1 year ago |
| MACD: Sell Signal | May 30, 2025 | 1 year ago |
| SMA: Bearish | May 29, 2025 | 1 year ago |
| SMA: Bullish | May 27, 2025 | 1 year ago |
| MACD: Buy Signal | May 27, 2025 | 1 year ago |
| MACD: Sell Signal | May 20, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 14, 2025 | 1 year ago |
| MACD: Buy Signal | May 14, 2025 | 1 year ago |
| MACD: Sell Signal | May 8, 2025 | 1 year ago |
| SMA: Bearish | May 6, 2025 | 1 year ago |
| SMA: Bullish | May 5, 2025 | 1 year ago |
| SMA: Bearish | May 2, 2025 | 1 year ago |
| SMA: Bullish | May 1, 2025 | 1 year ago |
| MACD: Buy Signal | May 1, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 30, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 21, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 10, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 7, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 4, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 25, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 24, 2025 | 1 year ago |
| SMA: Bearish | Mar 13, 2025 | 1 year ago |
| SMA: Bullish | Mar 12, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 12, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 7, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 5, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 24, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 19, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 18, 2025 | 1 year ago |
| SMA: Bearish | Feb 14, 2025 | 1 year ago |
| SMA: Bullish | Feb 13, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 11, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 28, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 27, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 3, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 20, 2024 | 1 year ago |
Key statistics
- Market cap
- 12.01M
- Enterprise value
- 23.96M
- Trailing P/E
- 0.00
- Forward P/E
- -2.53
- PEG ratio
- 0.00
- Price / sales
- 0.37
- Price / book
- 0.80
- EPS (TTM)
- -2.60
- Beta
- 1.32
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -25.40%
- Revenue (TTM)
- 32.73M
- Revenue growth
- 2.20%
- Free cash flow
- 1.44M
- Total cash
- 5.48M
- Total debt
- 16.51M
- Return on equity
- -62.97%
- Shares outstanding
- 4.17M
- Short % of float
- 0.22%
- 50-day average
- 3.04
- 200-day average
- 3.51
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 16.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.40.
Financials — quick view
SSKN Revenue — quarterly 6.93M
SSKN Net income — quarterly -1.62M
SSKN EPS — quarterly -0.36
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | -0.53 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.03 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -1.00 | — | — |
| Mar 27, 2024 | Dec 1, 2023 | 0.00 | -0.40 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | -0.30 | — | — |
| Aug 9, 2023 | Jun 1, 2023 | 0.00 | -0.90 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 16, 2023 | CG Capital | reit | — | Outperform |
| Nov 3, 2020 | HC Wainwright & Co. | up | Neutral | Buy |
| Mar 17, 2020 | HC Wainwright & Co. | down | Buy | Neutral |
| Dec 9, 2019 | Ladenburg Thalmann | init | — | Buy |
| Nov 21, 2019 | Oppenheimer | init | — | Outperform |
| Dec 10, 2018 | Northland Capital Markets | init | — | Outperform |
About STRATA Skin Sciences, Inc.
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- strataskinsciences.com
News
- STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive Officer
- New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA's Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo
- Short Interest in Strata Skin Sciences, Inc. (NASDAQ:SSKN) Rises By 89.2%
- Hims & Hers Health (NYSE:HIMS) & Strata Skin Sciences (NASDAQ:SSKN) Head-To-Head Analysis
- Critical Comparison: Clover Health Investments (NASDAQ:CLOV) and Strata Skin Sciences (NASDAQ:SSKN)
- STRATA Skin Sciences Confirms Nasdaq Delisting
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- SSKN Stock Falls Despite Meta-Analysis Backs Excimer Laser's Efficacy
- Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Your note
Sign in to keep a note on SSKN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| 22NW, L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 15, 2023 | 0 |
| ACCELMED GROWTH PARTNERS, L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jul 14, 2024 | 5,767,340 |
| GEIGER URI | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Jul 14, 2024 | 0 |
| GOV SHMUEL | Chief Operating Officer | Purchase | Nov 30, 2023 | 20,000 |
| LESOVITZ CHRISTOPHER | Chief Financial Officer | Purchase | Aug 9, 2023 | 38,282 |
| MOCCIA ROBERT JOSEPH | Chief Executive Officer | Purchase | Aug 9, 2023 | 235,300 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| 22NW, LP | 12.87% | 536,995 | 1.55M | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 9.68% | 403,917 | 1.16M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 2.51% | 104,521 | 301.02K | Sep 29, 2024 |
| Vanguard Group Inc | 2.02% | 84,316 | 242.83K | Sep 29, 2024 |
| Citadel Advisors Llc | 0.52% | 21,852 | 62.93K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.40% | 16,862 | 48.56K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.42% | 59,324 | 170.85K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.56% | 23,545 | 67.81K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.26% | 10,825 | 31.18K | Oct 30, 2024 |
| Perritt Ultra MicroCap Fund | 0.24% | 10,000 | 28.80K | Jul 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.07% | 3,055 | 8.80K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.04% | 1,744 | 5.02K | Oct 30, 2024 |